Peer-Reviewed Publications

      Multispecies aerosol evolution and deposition in a human respiratory tract cast model

      Asgari, M.; Lucci, F.; Kuczaj, A. K.
      Published
      Nov 28, 2020
      DOI
      10.1016/j.jaerosci.2020.105720
      Link to publication
      Topic
      Summary

      Accurate predictions of aerosol transport, evolution, and deposition in the human airways are crucial for inhalation dosimetry investigations. Inhaled aerosol transported through the airways undergoes thermodynamic changes due to changes in temperature and humidity. Aerosol evolution processes are particularly important for liquid multispecies aerosols. These aerosols are sensitive to condensation and/or evaporation dynamics, which can modify gas/liquid partitioning of each species and particle size distribution. In this manuscript, we present computational fluid dynamics simulations of complex aerosol mixtures in a realistic geometry of the human respiratory tract cast model. We used a publicly available computational framework, AeroSolved, developed for simulation of evolving multispecies aerosol mixtures. We evaluated the dynamics of liquid particles in physiologically relevant conditions of 100% relative humidity at the temperature of 37°C. We studied two separate inhalation flow scenarios: in the first case, a warm aerosol at 50°C was inhaled and subsequently cooled down while flowing in the airways. In the second case, an aerosol at room temperature was inhaled and heated up to the temperature of 37°C. Our results demonstrated that aerosol evolution mainly occurs in the upper segments of the airways (throat and trachea) at the very short timescales. Apart from showing the significant influence of temperature and humidity conditions on aerosol dynamics and evolution, we also measured aerosol deposition fluxes investigating the dependence of the delivered aerosol mass on evolution mechanisms. We showed that the delivered regional mass of each species depends on the physico-chemical properties of the mixture, and it is also significantly influenced by the airways’ humidity and thermal conditions. It was also shown that the species-specific properties of the liquid mixture (e.g., activity coefficient) play an important role in gas/liquid partitioning of the species. With AeroSolved such dependencies can be further investigated with greater attention towards specific needs and physiologically important conditions (e.g., transient flow inhalation patterns, aerosol mixture composition and its properties).

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.